Cargando…

An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats

BACKGROUND: Calcitonin is used as a treatment to reduce the blood calcium concentration in hypercalcemia and to improve bone mass in osteoporosis. An analgesic effect of calcitonin has been observed and reported in clinical situations. Ovariectomaized (OVX) rats exhibit the same hormonal changes as...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Bunji, Kikuchi, Shin-ichi, Konno, Shin-ichi, Sekiguchi, Miho
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654564/
https://www.ncbi.nlm.nih.gov/pubmed/19077321
http://dx.doi.org/10.1186/1471-2474-9-164
_version_ 1782165388564365312
author Takayama, Bunji
Kikuchi, Shin-ichi
Konno, Shin-ichi
Sekiguchi, Miho
author_facet Takayama, Bunji
Kikuchi, Shin-ichi
Konno, Shin-ichi
Sekiguchi, Miho
author_sort Takayama, Bunji
collection PubMed
description BACKGROUND: Calcitonin is used as a treatment to reduce the blood calcium concentration in hypercalcemia and to improve bone mass in osteoporosis. An analgesic effect of calcitonin has been observed and reported in clinical situations. Ovariectomaized (OVX) rats exhibit the same hormonal changes as observed in humans with osteoporosis and are an animal model of postmenopousal osteoporosis. The aim of this study to investigate antinociceptive effect of calcitonin in OVX rats using the immunohistochemical study. METHODS: We assessed the antinociceptive effects of calcitonin in an ovariectomized (OVX) rat model, which exhibit osteoporosis and hyperalgesia, using the immunohistochemical method. Fifteen rats were ovariectomized bilaterally, and ten rats were received the same surgery expected for ovariectomy as a sham model. We used five groups: the OVX-CT (n = 5), the sham-CT (n = 5), and the OVX-CT-pcpa (n = 5) groups recieved calcitonin (CT: 4 U/kg/day), while OVX-vehi (n = 5) and the sham-vehi (n = 5) groups received vehicle subcutaneously 5 times a week for 4 weeks. The OVX-CT-pcpa-group was given traperitoneal injection of p-chlorophenylalanine (pcpa; an inhibitor of serotonin biosynthesis) (100 mg/kg/day) in the last 3 days of calcitonon injection. Two hours after 5% formalin (0.05 ml) subcutaneously into the hind paw, the L5 spinal cord were removed and the number of Fos-immunoreactive (ir) neurons were evaluated using the Mann-Whitney-U test. RESULTS: The numbers of Fos-ir neurons in the OVX-CT and sham-CT groups were significantly less than in the OVX-vehi and sham-vehi groups, respectively (p = 0.0090, p = 0.0090). The number of Fos-ir neurons in the OVX-CT-pcpa-group was significantly more than that of the OVX-CT-group (p = 0.0283), which means pcpa inhibits calcitonin induced reduction of c-Fos production. CONCLUSION: The results in this study demonstrated that 1) the increase of c-Fos might be related to hyperalgesia in OVX-rats. 2) Calcitonin has an antinociceptive effect in both OVX and sham rats. 3) The central serotonergic system is involved in the antinociceptive properties of calcitonin.
format Text
id pubmed-2654564
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26545642009-03-13 An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats Takayama, Bunji Kikuchi, Shin-ichi Konno, Shin-ichi Sekiguchi, Miho BMC Musculoskelet Disord Research Article BACKGROUND: Calcitonin is used as a treatment to reduce the blood calcium concentration in hypercalcemia and to improve bone mass in osteoporosis. An analgesic effect of calcitonin has been observed and reported in clinical situations. Ovariectomaized (OVX) rats exhibit the same hormonal changes as observed in humans with osteoporosis and are an animal model of postmenopousal osteoporosis. The aim of this study to investigate antinociceptive effect of calcitonin in OVX rats using the immunohistochemical study. METHODS: We assessed the antinociceptive effects of calcitonin in an ovariectomized (OVX) rat model, which exhibit osteoporosis and hyperalgesia, using the immunohistochemical method. Fifteen rats were ovariectomized bilaterally, and ten rats were received the same surgery expected for ovariectomy as a sham model. We used five groups: the OVX-CT (n = 5), the sham-CT (n = 5), and the OVX-CT-pcpa (n = 5) groups recieved calcitonin (CT: 4 U/kg/day), while OVX-vehi (n = 5) and the sham-vehi (n = 5) groups received vehicle subcutaneously 5 times a week for 4 weeks. The OVX-CT-pcpa-group was given traperitoneal injection of p-chlorophenylalanine (pcpa; an inhibitor of serotonin biosynthesis) (100 mg/kg/day) in the last 3 days of calcitonon injection. Two hours after 5% formalin (0.05 ml) subcutaneously into the hind paw, the L5 spinal cord were removed and the number of Fos-immunoreactive (ir) neurons were evaluated using the Mann-Whitney-U test. RESULTS: The numbers of Fos-ir neurons in the OVX-CT and sham-CT groups were significantly less than in the OVX-vehi and sham-vehi groups, respectively (p = 0.0090, p = 0.0090). The number of Fos-ir neurons in the OVX-CT-pcpa-group was significantly more than that of the OVX-CT-group (p = 0.0283), which means pcpa inhibits calcitonin induced reduction of c-Fos production. CONCLUSION: The results in this study demonstrated that 1) the increase of c-Fos might be related to hyperalgesia in OVX-rats. 2) Calcitonin has an antinociceptive effect in both OVX and sham rats. 3) The central serotonergic system is involved in the antinociceptive properties of calcitonin. BioMed Central 2008-12-15 /pmc/articles/PMC2654564/ /pubmed/19077321 http://dx.doi.org/10.1186/1471-2474-9-164 Text en Copyright © 2008 Takayama et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Takayama, Bunji
Kikuchi, Shin-ichi
Konno, Shin-ichi
Sekiguchi, Miho
An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
title An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
title_full An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
title_fullStr An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
title_full_unstemmed An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
title_short An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
title_sort immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654564/
https://www.ncbi.nlm.nih.gov/pubmed/19077321
http://dx.doi.org/10.1186/1471-2474-9-164
work_keys_str_mv AT takayamabunji animmunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT kikuchishinichi animmunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT konnoshinichi animmunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT sekiguchimiho animmunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT takayamabunji immunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT kikuchishinichi immunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT konnoshinichi immunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats
AT sekiguchimiho immunohistochemicalstudyoftheantinociceptiveeffectofcalcitonininovariectomizedrats